DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Here, we use multiple mouse models that recapitulate the full range of dystroglycanopathy neuropathology to address several outstanding questions related to the role of Dystroglycan at inhibitory synapses.